Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Roumie CL et al. – The authors found an increased risk of cardiovascular events among all and new current users of rofecoxib, valdecoxib, and indomethacin in patients with no history of CVD. Among patients with CVD, all and new current rofecoxib use was associated with an increased risk of a cardiovascular event.

Related Articles

Using Nontraditional Risk Factors in Coronary Heart Disease Risk Assessment: U.S. Preventive Services Task Force Recommendation Statement
Annals of Internal Medicine, 10/06/09    Relevance Score: 91%

Adherence to the Mediterranean Diet and Risk of Coronary Heart Disease in the Spanish EPIC Cohort Study
American Journal of Epidemiology, 11/11/09    Relevance Score: 90%

Advancing the hypothesis that geographic variations in risk factors contribute relatively little to observed geographic variations in heart disease and stroke mortality
Preventive Medicine, 10/16/09    Relevance Score: 89%

Gender Differences and Symptom Presentation in Noncardiac Chest Pain
The Female Patient, 10/07/09    Relevance Score: 88%

Indications for Percutaneous Endoscopic Gastrostomy and Procedure-related Outcome
Journal of Pediatric Gastroenterology and Nutrition, 10/13/09    Relevance Score: 87%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address